KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Other Operating Expenses: 2017-2019

Historic Other Operating Expenses for BioNTech SE (BNTX) over the last 3 years, with Dec 2019 value amounting to $2.2 million.

  • BioNTech SE's Other Operating Expenses fell 20.00% to $176.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $814.0 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2019, which is 60.22% down from last year.
  • Latest data reveals that BioNTech SE reported Other Operating Expenses of $2.2 million as of FY2019, which was down 60.22% from $5.5 million recorded in FY2018.
  • In the past 5 years, BioNTech SE's Other Operating Expenses registered a high of $5.5 million during FY2018, and its lowest value of $2.2 million during FY2019.
  • Moreover, its 3-year median value for Other Operating Expenses was $2.3 million (2017), whereas its average is $3.3 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 137.33% in 2018, then tumbled by 60.22% in 2019.
  • BioNTech SE's Other Operating Expenses (Yearly) stood at $2.3 million in 2017, then surged by 137.33% to $5.5 million in 2018, then plummeted by 60.22% to $2.2 million in 2019.